Product Images Imiquimod

This text represents the results of a clinical trial with Imiquimod Cream Vehicle. 209 people were enrolled, divided into two groups of 109 and 100 individuals. Some individuals completed the full 16 weeks of the treatment, while others withdrew early, and some did not achieve a clear outcome. Following the treatment, some individuals remained clear, while others experienced recurrences, and some were lost to follow-up.*

This is a description of a topical medication (cream) called Imiquimod which is for dermatologic use only, not for ophthalmic use. It comes in single-use packets of 0.5 g each with a net weight of 0.25 grams per packet and six packets per box. Besides the active ingredient, Imiquimod 2.5 m, the cream contains a variety of inactive ingredients such as polysorbate, purified water, and alcohol. The cream should be stored at a temperature within the range of 47°F to 77°F to avoid freezing. It is important to keep the medication out of the reach of children. There is also a lot number and an expiry date provided, and a warning to consult the accompanying insert for dosage recommendations, directions for use, and other important prescribing information. The medication is manufactured by Taro Pharmaceutical Industries Ltd, Israel, and distributed by Taro Pharmaceuticals USA Inc, Hawthorne, NY 10532, USA.*